These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 6770000)

  • 1. Development of a hemolytic assay for mouse C2 and determination of its genetic control.
    Gorman JC; Jackson R; Desantola JR; Shreffler D; Atkinson JP
    J Immunol; 1980 Jul; 125(1):344-51. PubMed ID: 6770000
    [No Abstract]   [Full Text] [Related]  

  • 2. A simple one-step hemolytic assay for C2 with C2-deficient human serum.
    Ngan BY; Gelfand EW; Minta JO
    J Immunol; 1977 Mar; 118(3):736-41. PubMed ID: 321681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and characterization of a hemolytic assay for mouse C4.
    Atkinson JP; McGinnis K; Shreffler D
    J Immunol Methods; 1980; 33(4):351-68. PubMed ID: 6768807
    [No Abstract]   [Full Text] [Related]  

  • 4. Analyses of the Ss and Slp proteins in a hemolytic assay for murine C41.
    Atkinson JP; McGinnis KM; Peterein J; Shreffler DC
    Immunobiology; 1980; 158(1-2):5-9. PubMed ID: 7203520
    [No Abstract]   [Full Text] [Related]  

  • 5. IgG and complement-mediated tissue damage in the absence of C2: evidence of a functionally active C2-bypass pathway in a guinea pig model.
    Wagner E; Platt JL; Howell DN; Marsh HC; Frank MM
    J Immunol; 1999 Sep; 163(6):3549-58. PubMed ID: 10477630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Linkage of total deficiency of the second component (C2) of the complement system and of genetic C2-polymorphism to the major histocompatibility complex of the guinea pig.
    Bitter-Suermann D; Hoffmann T; Burger R; Hadding U
    J Immunol; 1981 Aug; 127(2):608-12. PubMed ID: 7252150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemolytic efficiency of cell-bound IgM: evidence that IgM-C1 complexes activate C4 molecules not hemolytic with homologous C2--C9.
    Ejzemberg R; Borsos T
    J Immunol; 1982 Apr; 128(4):1600-2. PubMed ID: 7061844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feline (cat) hemolytic complement optimal testing conditions.
    Barta O; Oyekan PP
    Am J Vet Res; 1981 Mar; 42(3):378-81. PubMed ID: 6791533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased complement efficiency through control of ionic strength and temperature.
    Linscott WD
    J Immunol; 1971 Sep; 107(3):698-704. PubMed ID: 5572091
    [No Abstract]   [Full Text] [Related]  

  • 10. A hemolytic assay for clinical investigation of human C2.
    Joisel F; Leroux-Nicollet I; Lebreton JP; Fontaine M
    J Immunol Methods; 1983 Apr; 59(2):229-35. PubMed ID: 6841978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biosynthesis of a structurally abnormal C2 complement protein by macrophages from C2-deficient guinea pigs.
    Goldberger G; Cole FS; Einstein LP; Auerbach HS; Bitter-Suermann D; Colten HR
    J Immunol; 1982 Nov; 129(5):2061-5. PubMed ID: 6922142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of antibody on activation of human complement (alternative pathway) by rabbit red cells: kinetic study [proceedings].
    Hosselet M; Verloes R; Kanarek L
    Arch Int Physiol Biochim; 1979 Oct; 87(4):816-8. PubMed ID: 93922
    [No Abstract]   [Full Text] [Related]  

  • 13. Requirement for the alternative pathway as well as C4 and C2 in complement-dependent hemolysis via the lectin pathway.
    Suankratay C; Zhang XH; Zhang Y; Lint TF; Gewurz H
    J Immunol; 1998 Mar; 160(6):3006-13. PubMed ID: 9510205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of the eighth component of complement (C8) by ethylenediaminetetra-acetate (EDTA).
    Schultz DR; Zarco RM
    J Immunol; 1970 Feb; 104(2):279-88. PubMed ID: 4983887
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunogenicity of hylan g-f 20 in Guinea pigs and mice.
    Sasaki M; Miyazaki T; Nakamura T; Takahashi T; Miyauchi S; Iwata H
    J Rheumatol; 2004 May; 31(5):943-50. PubMed ID: 15124255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Classical pathway of complement activation in mammalian kidneys.
    Zwirner J; Felber E; Burger R; Bitter-Suermann D; Riethmüller G; Feucht HE
    Immunology; 1993 Oct; 80(2):162-7. PubMed ID: 8262545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biosynthesis of complement components.
    McPhaden AR; Lappin D; Whaley K
    J Clin Lab Immunol; 1982 May; 8(1):1-8. PubMed ID: 7047744
    [No Abstract]   [Full Text] [Related]  

  • 18. General pharmacology of the new antimuscarinic compound vamicamide.
    Yamamoto T; Honbo T; Tokoro K; Kojimoto Y; Kodama R; Ohtsuka M; Shimomura K
    Arzneimittelforschung; 1995 Dec; 45(12):1274-84. PubMed ID: 8595084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytotoxicity by stored human breast-milk: possible contribution of complement system.
    Ogundele MO
    Cell Biol Int; 1999; 23(8):585-8. PubMed ID: 10704243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased susceptibility of complement factor B/C2 double knockout mice and mannan-binding lectin knockout mice to systemic infection with Candida albicans.
    Held K; Thiel S; Loos M; Petry F
    Mol Immunol; 2008 Sep; 45(15):3934-41. PubMed ID: 18672286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.